Tocilizumab vs standard care on preventing worsening in patients hospitalized with COVID-19 pneumonia

(JAMA Network) Researchers in this randomized clinical trial compared the effect of early administration of tocilizumab with standard therapy in preventing clinical worsening in patients hospitalized with COVID-19 pneumonia.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news